Social comments show how patients, caregivers, and HCPs interpret your content in real time. They reveal where questions keep surfacing, where misinformation starts to take hold, and how people actually talk about symptoms, treatment decisions, and trust.
Most teams still look at that activity through a risk lens. In a regulated environment, that is understandable. But it also leaves insight on the table.
LiveWorld’s white paper, Turning UGC into Insight: The Untapped Value in Pharma Conversations, identifies how moderated conversations become an insight pipeline, what recurring questions, misinformation themes, and sentiment shifts actually signal, and how those signals can inform content, response planning, and education strategy.
The takeaway is simple: UGC is not just something to monitor. It is something to learn from.
